ClinicalTrials.Veeva

Menu

Dentinal Hypersensitivity Reduction Efficacy Study

Colgate-Palmolive logo

Colgate-Palmolive

Status and phase

Enrolling
Phase 3

Conditions

Sensitivity, Tooth

Treatments

Drug: Colgate Dental Cream Toothpaste
Drug: CSPR Toothpaste

Study type

Interventional

Funder types

Industry

Identifiers

NCT06960148
CRO-2025-02-SEN-CSPR-YPZ

Details and patient eligibility

About

Assess the clinical efficacy of CSPR Toothpaste containing 8% arginine to provide dentinal hypersensitivity relief

Full description

The objective of this study is to assess the clinical efficacy of CSPR Toothpaste containing 8% arginine to provide dentinal hypersensitivity relief (tactile and air blast) at instant, 3 days, 4 weeks and 8 weeks in comparison to Colgate Cavity Protection Toothpaste over an eight-week period.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and female subjects, ages 18-70, inclusive.
  • Availability for the eight-week duration of the study.
  • Two sensitive teeth, which must be anterior to the molars, and demonstrate cervical erosion/abrasion or gingival recession.
  • Qualifying response to tactile stimuli (Yeaple probe) as defined by a score between 10-50 gms. of force.
  • Qualifying response to the air blast stimuli as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale.
  • Subjects need to satisfy the qualifying response to stimuli for both the parameters assessed (tactile or air) on two teeth to be entered into the study.
  • Good general health with no known allergies to products being tested.
  • Use of a non-desensitizing dentifrice for three months prior to entry into the study.
  • Signed Informed Consent Form.

Exclusion criteria

  • Gross oral pathology, chronic disease, or history of allergy to test products. 2. Advanced periodontal disease or treatment for periodontal disease (including surgery) within the past twelve months.
  • Sensitive teeth with a mobility greater than one.
  • Teeth with extensive/defective restorations (including prosthetic crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures.
  • Current use of anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs, or daily use of analgesics.
  • Participation in a desensitizing dentifrice study or regular use of a desensitizing dentifrice within the past three months.
  • Current participation in any other clinical study.
  • Pregnant or lactating subjects.
  • Allergies to oral care products, personal care consumer products, or their ingredients.
  • Medical condition which prohibits not eating/drinking for 4 hours.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups

Test Toothpaste
Experimental group
Description:
Subjects will be instructed to brush their teeth with their assigned teeth dentifrice and toothbrush twice daily
Treatment:
Drug: CSPR Toothpaste
Control toothpaste
Active Comparator group
Description:
Subjects will be instructed to brush their teeth with their assigned teeth dentifrice and toothbrush twice daily
Treatment:
Drug: Colgate Dental Cream Toothpaste

Trial contacts and locations

1

Loading...

Central trial contact

Zhi Zhou, DDS,PhD; Deyu Hu, DDS,MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems